ARTICLE | Clinical News
Icatibant: Phase II
February 17, 2003 8:00 AM UTC
Jerini began a European Phase II trial in 80 patients. Icatibant was licensed from AVE and has Orphan Drug designation in Europe. The compound is in a Phase IIa trial to treat late-stage liver cirrhos...